Exact Mass: 384.26643060000004
Exact Mass Matches: 384.26643060000004
Found 391 metabolites which its exact mass value is equals to given mass value 384.26643060000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Megestil
CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9660; ORIGINAL_PRECURSOR_SCAN_NO 9655 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9556; ORIGINAL_PRECURSOR_SCAN_NO 9555 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9613; ORIGINAL_PRECURSOR_SCAN_NO 9611 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9650; ORIGINAL_PRECURSOR_SCAN_NO 9648 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9684; ORIGINAL_PRECURSOR_SCAN_NO 9681 CONFIDENCE standard compound; INTERNAL_ID 727; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9604; ORIGINAL_PRECURSOR_SCAN_NO 9603 D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone CONFIDENCE standard compound; INTERNAL_ID 2814 CONFIDENCE standard compound; INTERNAL_ID 8750 D000970 - Antineoplastic Agents
Bufogein
Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Ibutilide
Ibutilide is only found in individuals that have used or taken this drug. It is a Class III antiarrhythmic agent that is indicated for acute cardioconversion of atrial fibrillation and atrial flutter of a recent onset to sinus rhythm. [Wikipedia]Ibutilide is a pure class III antiarrhythmic drug, used intravenously against atrial flutter and fibrillation. At a cellular level it exerts two main actions: induction of a persistent Na+ current sensitive to dihydropyridine Ca2+ channel blockers and potent inhibition of the cardiac rapid delayed rectifier K+ current, by binding within potassium channel pores. In other words, Ibutilide binds to and alters the activity of hERG potassium channels, delayed inward rectifier potassium (IKr) channels and L-type (dihydropyridine sensitive) calcium channels C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
Ethynodiol Diacetate
Ethynodiol Diacetate is only found in individuals that have used or taken this drug. It is a synthetic progestational hormone used alone or in combination with estrogens as an oral contraceptive. [PubChem]Binds to the progesterone and estrogen receptors. Target cells include the female reproductive tract, the mammary gland, the hypothalamus, and the pituitary. Once bound to the receptor, progestins like Ethynodiol Diacetate will slow the frequency of release of gonadotropin releasing hormone (GnRH) from the hypothalamus and blunt the pre-ovulatory LH (luteinizing hormone) surge. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
ST 24:5;O4
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones Same as: D01617 D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents Same as: D01294
Estra-1,3,5(10)-triene-3,16alpha-diol dipropionate
Acequinocyl
An acetate ester consisting of 1,4-naphthoquinone bearing acetoxy and dodecyl substituents at positions 2 and 3 respectively.
Persicaxanthin
Persicaxanthin is found in european plum. Persicaxanthin is isolated from plums Prunus domestic Isolated from plums Prunus domestica. Persicaxanthin is found in fruits and european plum.
(-)-Pyrifolidine
(-)-Pyrifolidine is an alkaloid from Aspidosperma quebracho-blanco (quebracho). Alkaloid from Aspidosperma quebracho-blanco (quebracho).
Persicachrome
(3S,5R,8S)-Persicachrome is found in fruits. (3S,5R,8S)-Persicachrome is a constituent of flesh of cling peaches (Prunus persica). Constituent of flesh of cling peaches (Prunus persica). (3S,5R,8S)-Persicachrome is found in fruits.
N-Palmitoyl Glutamine
C21H40N2O4 (384.29879200000005)
N-palmitoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Palmitic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Palmitoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Palmitoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
N-Myristoyl Arginine
N-myristoyl arginine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Myristic acid amide of Arginine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Myristoyl Arginine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Myristoyl Arginine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
16-Nitroxystearate
C22H42NO4 (384.31136720000006)
7-[(1S,2R,3R,4R)-3-(3-Hydroxy-4-phenylpent-1-enyl)-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
C22H32N4O2 (384.25251319999995)
Bufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents
Estradiol dipropionate
Estradiol enanthate
Magestin
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
5-hydroxy-4-isopropyl-1-methyl-7-(3-oxobutyl)bicyclo[4.1.0]hept-3-yl cinnamate
Decahydro-alpha,4a-dimethyl-8-methylene-7-(1-oxo-3-phenylpropoxy)-2-naphthaleneacetic acid
Epipolasinthiourea A
25-Hydroxy-13(24),15,17-cheilanthatrien-18,25-olide
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol
8-(4-Hydroxycinnamoyl)-(4beta,5alpha,8alpha)-1(10)-Guaiaene-8,11-diol|<4S,5S,7S,8S>-8-p-Coumaroyloxy-1(10)-guaien-11-ol|[4S,5S,7S,8S]-8-p-Coumaroyloxy-1(10)-guaien-11-ol
(1E,4S,5E,7R)-7-O-beta-D-glucopyranosylgermacra-1(10),5-diene
N-Methyl-N-(2,3,11a-trimethyl-2,3,3a,4,5,5a,5b,6,8,9,10,11,11a,11b,12,13-hexadecahydro-1H-2-aza-pentaleno[1,6a-a]phenanthren-9-yl)-acetamide
plakortolide Q
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
(3beta,22E)-3-Hydroxy-24-norcholesta-5,22-dien-7-one
5alpha,6alpha-epoxy-26,27-dinorergosta-7,22(E)-dien-3beta-ol
(16S)-23,24,25,26,27-pentanorcycloartan-3-one-16,22-olide|(5alpha,16beta,20S)-23,24,25,26,27-Pentanor-3-oxocycloartan-22,16-olide
3-(Dimethylamino)pregna-14,16-dien-20-yl(methyl)formamide
isobutyl 13-(1,3-benzdioxolo-5)trideca-2E,4E,12E-trienoate
3beta,16beta-dihydroxy-bufa-8(14),20,22-trienolide
1-(2,6-Dihydroxy-4-methoxyphenyl)-11-phenyl-1-undecanone|11-phenylundecanoyl-2,6-dihydroxy-4-methoxybenzene
(20S)-3beta-N-methyl-20-(N-acetyl-N-methylamino)-pregna-5,14-diene
(all-Z)-form-1-(2,4,6-Trihydroxyphenyl)-6,9,12,15-octadecatetraen-1-one,|phloroglucinol
(10S)-3c,8c,12c,14c,17c-Pentahydroxy-10r,13c-dimethyl-17t-((Xi)-1-hydroxy-aethyl)-(5tH,9tH)-hexadecahydro-1H-cyclopenta[a]phenanthren|(3?,5?,12?,14?,17S,20R)-Pregnane-3,8,12,14,17,20-hexol|3beta,8beta,12beta,14,17beta-Pentahydroxy-10,13-dimethyl-17alpha-((Xi)-1-hydroxy-aethyl)-5alpha,14beta-gonan|5alpha,14beta,17betaH-Pregnanhexol-(3beta,8,12beta,14,17,20xi)|5alpha-Dihydrosarcostin|diginanehexol-(3beta,8,12beta,14,17,20xi)|Diginanhexol-(3beta,8,12beta,14,17,20xi)|Dihydrosarcostin
lehualide E
A member of the class of 2-pyranones that is 2H-pyran-2-one substituted by methoxy groups at positions 3 and 4, a methyl group at position 5 and a (2E)-3-methyl-9-phenylnon-2-en-1-yl group at position 6. It has been isolated from the marine sponge of the genus Plakortis.
20(10->5)abeo-4,12-diacetoxy-4,5-secoabieta-5(10),6,8,11,13-pentaene|8-[4-(acetyloxy)-4-methylpentyl]-7-methyl-3-(1-methylethyl)naphthalen-2-yl acetate|diacetylcalocediol
(2R*,5S*,7S*,10S*)-10-methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
3-oxo-choladien-(1.4)-oic acid-(24)-methyl ester|3-Oxo-choladien-(1.4)-saeure-(24)-methylester|choladiene-1,4 one-3 oate-24 de methyle|methyl 3-oxochola-1,4-dien-24-oate
(1R,4E,8R,10R)-8-O-[(E)-p-coumaroyl]-1,10-epoxyhumula-4(5)-en-8-ol
(1E,4R,5R,8R)-8-O-[(E)-p-coumaroyl]-4,5-epoxyhumula-1(10)-en-8-ol
(1E,5R,8R)-8-O-[(E)-p-coumaroyl]-5-hydroxyhumula-1(10),4-(15)-dien-8-ol
(3beta,22E)-3-Hydroxy-26,27-dinorcholesta-5,22-diene-7,24-dione
9-Hydroxy-cis-12-octadecenoat|isoricinoleic acid
C22H44O3Si (384.30595539999996)
23,6alpha-epoxy-labd-8,13(14),17-trien-16(R),19-olide
(3-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) heptanoate
Me ester,di-Ac-(7S,8Z)-7,16-Dihydroxy-8-hexadecenoic acid
(23E)-3beta-hydroxy-27-norcholesta-5,23-dien-25-one
7-oxo-chola-3,5-dien-24-oic acid methyl ester|7-Oxo-chola-3,5-dien-24-saeure-methylester|methyl 7-oxochola-3,5-dien-24-oate
Resibufogenin
Annotation level-1 Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Megestrol acetate
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D019167 - Appetite Stimulants C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D000970 - Antineoplastic Agents
[(8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
C24H32O4_2-Propenoic acid, 3-phenyl-, (1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-(1-methylethyl)-11-oxabicyclo[8.1.0]undec-6-en-4-yl ester, (2E)
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate
Zipeprol
R - Respiratory system > R05 - Cough and cold preparations > R05D - Cough suppressants, excl. combinations with expectorants C78273 - Agent Affecting Respiratory System > C66917 - Antitussive Agent D019141 - Respiratory System Agents > D000996 - Antitussive Agents D002491 - Central Nervous System Agents
5-[(Z)-12-(3,5-dihydroxyphenyl)dodec-8-enyl]benzene-1,3-diol_major
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_99.4\\%
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_major
[4,5-dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-5,6,7,8a-tetrahydro-1H-naphthalen-1-yl] hexanoate_84.2\\%
Ala Pro Val Val
C18H32N4O5 (384.23725820000004)
Ala Val Pro Val
C18H32N4O5 (384.23725820000004)
Ala Val Val Pro
C18H32N4O5 (384.23725820000004)
Gly Ile Pro Val
C18H32N4O5 (384.23725820000004)
Gly Ile Val Pro
C18H32N4O5 (384.23725820000004)
Gly Leu Pro Val
C18H32N4O5 (384.23725820000004)
Gly Leu Val Pro
C18H32N4O5 (384.23725820000004)
Gly Pro Ile Val
C18H32N4O5 (384.23725820000004)
Gly Pro Leu Val
C18H32N4O5 (384.23725820000004)
Gly Pro Val Ile
C18H32N4O5 (384.23725820000004)
Gly Pro Val Leu
C18H32N4O5 (384.23725820000004)
Gly Val Ile Pro
C18H32N4O5 (384.23725820000004)
Gly Val Leu Pro
C18H32N4O5 (384.23725820000004)
Gly Val Pro Ile
C18H32N4O5 (384.23725820000004)
Gly Val Pro Leu
C18H32N4O5 (384.23725820000004)
Ile Gly Pro Val
C18H32N4O5 (384.23725820000004)
Ile Gly Val Pro
C18H32N4O5 (384.23725820000004)
Ile Pro Gly Val
C18H32N4O5 (384.23725820000004)
Ile Pro Val Gly
C18H32N4O5 (384.23725820000004)
Ile Val Gly Pro
C18H32N4O5 (384.23725820000004)
Ile Val Pro Gly
C18H32N4O5 (384.23725820000004)
Leu Gly Pro Val
C18H32N4O5 (384.23725820000004)
Leu Gly Val Pro
C18H32N4O5 (384.23725820000004)
Leu Pro Gly Val
C18H32N4O5 (384.23725820000004)
Leu Pro Val Gly
C18H32N4O5 (384.23725820000004)
Leu Val Gly Pro
C18H32N4O5 (384.23725820000004)
Leu Val Pro Gly
C18H32N4O5 (384.23725820000004)
Pro Ala Val Val
C18H32N4O5 (384.23725820000004)
Pro Gly Ile Val
C18H32N4O5 (384.23725820000004)
Pro Gly Leu Val
C18H32N4O5 (384.23725820000004)
Pro Gly Val Ile
C18H32N4O5 (384.23725820000004)
Pro Gly Val Leu
C18H32N4O5 (384.23725820000004)
Pro Ile Gly Val
C18H32N4O5 (384.23725820000004)
Pro Ile Val Gly
C18H32N4O5 (384.23725820000004)
Pro Leu Gly Val
C18H32N4O5 (384.23725820000004)
Pro Leu Val Gly
C18H32N4O5 (384.23725820000004)
Pro Val Ala Val
C18H32N4O5 (384.23725820000004)
Pro Val Gly Ile
C18H32N4O5 (384.23725820000004)
Pro Val Gly Leu
C18H32N4O5 (384.23725820000004)
Pro Val Ile Gly
C18H32N4O5 (384.23725820000004)
Pro Val Leu Gly
C18H32N4O5 (384.23725820000004)
Pro Val Val Ala
C18H32N4O5 (384.23725820000004)
Val Ala Pro Val
C18H32N4O5 (384.23725820000004)
Val Ala Val Pro
C18H32N4O5 (384.23725820000004)
Val Gly Ile Pro
C18H32N4O5 (384.23725820000004)
Val Gly Leu Pro
C18H32N4O5 (384.23725820000004)
Val Gly Pro Ile
C18H32N4O5 (384.23725820000004)
Val Gly Pro Leu
C18H32N4O5 (384.23725820000004)
Val Ile Gly Pro
C18H32N4O5 (384.23725820000004)
Val Ile Pro Gly
C18H32N4O5 (384.23725820000004)
Val Leu Gly Pro
C18H32N4O5 (384.23725820000004)
Val Leu Pro Gly
C18H32N4O5 (384.23725820000004)
Val Pro Ala Val
C18H32N4O5 (384.23725820000004)
Val Pro Gly Ile
C18H32N4O5 (384.23725820000004)
Val Pro Gly Leu
C18H32N4O5 (384.23725820000004)
Val Pro Ile Gly
C18H32N4O5 (384.23725820000004)
Val Pro Leu Gly
C18H32N4O5 (384.23725820000004)
Val Pro Val Ala
C18H32N4O5 (384.23725820000004)
Val Val Ala Pro
C18H32N4O5 (384.23725820000004)
Val Val Pro Ala
C18H32N4O5 (384.23725820000004)
(22E)-12α-Hydroxy-3-oxochola-1,4,22-trien-24-oic Acid
L-759,633
(-)-Pyrifolidine
Persicaxanthin
Persicachrome
4,5-Dihydroxy-3,4-bis(hydroxymethyl)-4a,8,8-trimethyl-1,4,4a,5,6,7,8,8a-octahydro-1-naphthalenyl hexanoate
Cardiogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
1-(2,4,6-Trihydroxyphenyl)-6Z,9Z,12Z,15Z-octadecatetraen-1-one
DICYCLOHEXYLAMINE (R)-3-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPROPANOATE
C21H40N2O4 (384.29879200000005)
TRIMETHYL CIS,CIS-1,3,5-TRIPROPYL-1,3,5-CYCLOHEXANETRICARBOXYLATE
Pyrimidine, 2-[4-[1-(1-cyclohexyl-1H-tetrazol-5-yl)-3-methylbutyl]-1-piperazinyl]- (9CI)
[2-(5-Carboxypentyl)-4,4-dimethyl-2-undecyl-1,3-oxazolidin-3-yl]o xidanyl
C22H42NO4 (384.31136720000006)
[(1S,3S,4S)-4-Amino-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic acid 1,1-dimethylethyl ester
tert-butyl 4-(2-oxospiro[cyclohexane-1,3-indole]-1-yl)piperidine-1-carboxylate
butyl prop-2-enoate,6-methylheptyl prop-2-enoate,prop-2-enoic acid
1-(2,6-Diisopropylphenyl)-3-(2,4,6-trimethylphenyl)-4,5-dihydroimidazolium chloride
C24H33ClN2 (384.23321280000005)
Estradiol enanthate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D004967 - Estrogens C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
[4-(4-propylcyclohexyl)phenyl] 4-butylcyclohexane-1-carboxylate
Desfuranoazadiradione
A limonoid that is azadiradione in which the furanyl group at position 17 is replaced by a hydrogen. It has been isolated from Azadirachta indica.
plakortolide R
An organic heterobicyclic compound that is a cyclic peroxy compound isolated from the Australian marine sponge Plakinastrella clathrata.
(2R)-2-cyclopentyl-2-hydroxy-N-[1-(4-methylpent-3-enyl)-4-piperidinyl]-2-phenylacetamide
Estra-1,3,5(10)-triene-3,16alpha-diol, dipropionate
1-[4-(Benzyloxy)-3-methoxyphenyl]-5-hydroxydecan-3-one
(S)-N-(4-Carbamimidoylbenzyl)-1-(3-Cyclohexylpropanoyl)pyrrolidine-2-Carboxamide
C22H32N4O2 (384.25251319999995)
Ethynodiol Diacetate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
Estradiol dipropionate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
Butyl [2-cyclohexyl-6-(pyrrolidin-1-yl)-1H-benzimidazol-5-yl]carbamate
C22H32N4O2 (384.25251319999995)
4,4'-Bis(2-hydroxyethylethylamino)-2,2'-dimethylazobenzene
C22H32N4O2 (384.25251319999995)
[3-carboxy-2-[(E)-pentadec-9-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
(E)-7-[3-[(E)-3-hydroxy-4-phenylpent-1-enyl]-7-oxabicyclo[2.2.1]heptan-2-yl]hept-5-enoic acid
4-(4,4-Dimethyl-3-oxido-2-tridecyl-1,3-oxazolidin-2-yl)butanoic acid
C22H42NO4- (384.31136720000006)
[3-carboxy-2-[(5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[(2R)-3-carboxy-2-[(3R,5Z,8Z)-3-hydroxytetradeca-5,8-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(8E,11E)-6-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(9E,11E)-7-hydroxytetradeca-9,11-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(8E,10E)-6-hydroxytetradeca-8,10-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(7E,9E)-5-hydroxytetradeca-7,9-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(8E,11E)-5-hydroxytetradeca-8,11-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(6E,8E)-4-hydroxytetradeca-6,8-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(6E,9E)-3-hydroxytetradeca-6,9-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(7E,10E)-4-hydroxytetradeca-7,10-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(10E,12E)-4-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(9E,12E)-6-hydroxytetradeca-9,12-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(10E,12E)-8-hydroxytetradeca-10,12-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(4E,6E)-2-hydroxytetradeca-4,6-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
[3-carboxy-2-[(E)-pentadec-10-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
[3-carboxy-2-[(E)-pentadec-2-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
[3-carboxy-2-[(E)-pentadec-7-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
[3-carboxy-2-[(E)-pentadec-6-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
[3-carboxy-2-[(E)-pentadec-5-enoyl]oxypropyl]-trimethylazanium
C22H42NO4+ (384.31136720000006)
(6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene
[(1R,2R,3S,4R,6E,10S)-2-hydroxy-6,10-dimethyl-3-propan-2-yl-11-oxabicyclo[8.1.0]undec-6-en-4-yl] (E)-3-phenylprop-2-enoate
acetic acid [(17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] ester
[(2S,4aS,10aR)-6-acetyloxy-1,1,4a-trimethyl-7-propan-2-yl-2,3,4,10a-tetrahydrophenanthren-2-yl] acetate
rel-(2R,5S,7S,10S)-10-Methyl-2-[(1-methyl-1-beta-D-fucopyranosyloxy)ethyl]-6-methylenespiro[4.5]decan-7-ol
A natural product found in Carthamus oxyacantha and Carduncellus mareoticus.
N-tert-butyl-2-[2-ethoxy-4-[(2-phenylethylamino)methyl]phenoxy]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(oxane-4-carbonyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
N-[[(2R,3S,4S)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(1R,5S)-6-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
N-[[(2S,3R,4R)-1-acetyl-3-[4-(1-cyclohexenyl)phenyl]-4-(hydroxymethyl)-2-azetidinyl]methyl]-N-methylpropanamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-[4-oxanyl(oxo)methyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-ethylacetamide
(1S,5R)-3-[(3-methoxyphenyl)methyl]-7-[4-(2-methylphenyl)phenyl]-3,6-diazabicyclo[3.1.1]heptane
2-cyclopropyl-1-[(2R,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
dihydrostemphyloxin I
An octahydronaphthalene that is stemphyloxin I in which the C=C bond of the enol moiety has been reduced to a C-C bond.
[(8S,9R,10S,13R,14R,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(2Z,10Z,12E,14Z)-16-(3,5-dihydroxyphenyl)-2-ethylidenehexadeca-10,12,14-trienoic acid
2-[2-(2,5-dimethyl-1-phenylpyrrol-3-yl)ethyl]-N,N,1-trimethylquinolin-1-ium-6-amine
[(1S)-3-carboxy-1-[(5E,7E)-3-hydroxytetradeca-5,7-dienoyl]oxypropyl]-trimethylazanium
C21H38NO5+ (384.27498380000003)
(2R)-1-(dimethylamino)-2-[4-[(4-methoxy-3-methylphenyl)methyl]-3,5-dihydro-2H-1,4-benzoxazepin-7-yl]propan-2-ol
[(8R,9R,10R,13S,14S,17S)-17-acetyl-6,10,13-trimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
(1-hexanoyloxy-3-hydroxypropan-2-yl) (Z)-tridec-9-enoate
(1-hydroxy-3-pentanoyloxypropan-2-yl) (Z)-tetradec-9-enoate
(1-acetyloxy-3-hydroxypropan-2-yl) (Z)-heptadec-9-enoate
(1-hydroxy-3-propanoyloxypropan-2-yl) (Z)-hexadec-9-enoate
(1-butanoyloxy-3-hydroxypropan-2-yl) (Z)-pentadec-9-enoate
2-[Hydroxy-(2-hydroxy-3-nonoxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C17H39NO6P+ (384.25148640000003)
Ibutilide
C - Cardiovascular system > C01 - Cardiac therapy > C01B - Antiarrhythmics, class i and iii > C01BD - Antiarrhythmics, class iii C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C93038 - Cation Channel Blocker
8Z,11Z,14Z,17Z,20Z,23Z-hexacosahexaenoic acid
A very long-chain omega-3 fatty acid that is hexacosanoic acid having six double bonds located at positions 8, 11, 14, 17, 20, 23 (the 8Z,11Z,14Z,17Z,20Z,23Z-isomer).
Scillarenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
12alpha-Hydroxy-3-oxochola-1,4,6-trien-24-oic Acid
soppiline C
A member of the class of resorcinols that is 16-(3,5-dihydroxyphenyl)hexadecanoic acid which carries cis double bonds at positions 10 and 14, a trans double bond at position 12, and an ethylidene group at position 2.